Vor Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.

About VOR

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. 

CEO
Jean-Paul Kress
CEOJean-Paul Kress
Employees
159
Employees159
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
159
Employees159

VOR Key Statistics

Market cap
244.92M
Market cap244.92M
Price-Earnings ratio
-1.27
Price-Earnings ratio-1.27
Dividend yield
Dividend yield
Average volume
80.09M
Average volume80.09M
High today
$1.97
High today$1.97
Low today
$1.47
Low today$1.47
Open price
$1.57
Open price$1.57
Volume
24.48M
Volume24.48M
52 Week high
$2.04
52 Week high$2.04
52 Week low
$0.1311
52 Week low$0.1311

People also own

Based on the portfolios of people who own VOR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.